Several predictors (eGFR, M protein, and cystatin C) were identified for NGAL, which itself correlated with CKD according to kidney disease improving global outcomes (KDIGO) in MM patients and markers of myeloma burden [52]. This evidence concerns the gene LCN2 and kidney disorder.